<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The objective of this study were (1) to evaluate the prevalence of anti-annexin II antibodies in patients with various <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and (2) to correlate anti-annexin II antibodies with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: Anti-annexin II antibodies and anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> were detected, using an enzyme-linked immunosorbent assay, in the serum of patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (n = 16), <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (n = 53), primary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren</z:e> syndrome (n = 71), systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (n = 17), systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (n = 18), and <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (n = 119) </plain></SENT>
<SENT sid="2" pm="."><plain>Healthy blood donors (n = 99) were used as controls </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Anti-annexin II antibodies were significantly more prevalent in patients with <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> (8.5%), especially <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (14.8%) and <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (10%), than in controls (2%) </plain></SENT>
<SENT sid="4" pm="."><plain>An inverse correlation was observed between anti-annexin II antibodies and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Annexin II can be recognized by antibodies in serum from patients with systemic <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Further studies are required to determine the clinical significance of anti-annexin II antibodies in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> and to determine their diagnostic value in discriminating clinical subgroups of patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>